Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Expensive Performer
1836.6000 7.20 (0.39%)
NSE May 05, 2025 15:31 PM
Volume: 1.2M
 

logo
Sun Pharmaceutical Industries Ltd.
10 Mar 2025
1836.60
0.39%
buy
by BOB Capital Markets Ltd.
Target: 2086 | Upside : 13.6%
BOB Capital Markets Ltd.
SUNP to acquire Checkpoint Therapeutic for US$ 4.10 a share, at ~66% premium to its last closing price. Deal valued at US$ 355mn
 
Promoters pledged 0.19% of shares in last quarter. Total pledge stands at 0.88% of promoter holdings
More from Sun Pharmaceutical Industries Ltd.
Recommended
IPOs This Week: Ather Energy and Four Other Listings, Plus New Public Issues
| 05 May 2025, 04:52PM
Market closes higher, Netweb Tech's Q4FY25 net profit grows 41.8% QoQ to Rs 43 crore
Trendlyne Marketwatch | 05 May 2025, 04:01PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022